Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Individualized Primary Clinical Target Volume Based on Margin Expansion for Nasopharyngeal Carcinoma: A Non-Inferiority, Multicenter, Randomized Phase 3 Trial

NCT07661771 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.

NCT NCT07661771
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07661771 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Individualized Primary Clinical Target Volume Based on Margin Expansion for Nasopharyngeal Carcinoma: A Non-Inferiority, Multicenter, Randomized Phase 3 Trial
Lead sponsor
Sun Yat-sen University
Phase
Phase 3
Overall status
Recruiting
Start date
July 24, 2026
Completion date
July 30, 2034
Enrollment
568 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

non-metastatic nasopharyngeal carcinoma